BluSmart, South Asia's premier EV ride-hailing service and EV charging infrastructure network, has reported a 77% ...

Although the company remains quiet about the project, this patent—filed with the United States Patent and Trademark Office (USPTO)—gives some clues as to Samsung’s vision for this next-generation ...

Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans to initiate in the ...

The current US Supreme Court has no fundamental understanding of a range of medical, engineering, technological, or ...

Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans to initiate in the secon ...

Reported total revenue of $10.3 million and GAAP Net Income of $0.6 million, or $0.02 per diluted shareEntered into an asset purchase agreement ...

Announced positive topline results from KARISMA-Endoxifen Phase 2 study which demonstrated that low doses of (Z)-endoxifen significantly reduced mammographic breast density (MBD), addressing a key bre ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

ON24 , a leading intelligent engagement platform for B2B sales and marketing, has once again been ranked as a top platform for enterprises in various G2 Fall 2024 Reports. Built to deliver ...